Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02744456Phase 1Completed
Phase 1, open-label, single-arm trial of losartan, amlodipine and hydrochlorothiazide in hypertension (HTN), sponsored by Columbia University. Primary endpoint: Participants satisfied with participating in N-of-1 trial at 4 months. Started Aug 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02744456.